Year |
Citation |
Score |
2018 |
Rahman MN, Vukomanovic D, Vlahakis JZ, Szarek WA, Nakatsu K, Jia Z. Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications. Current Medicinal Chemistry. PMID 30674243 DOI: 10.2174/0929867325666180606082512 |
0.397 |
|
2017 |
Lee MJY, Wang Y, Jiang Y, Li X, Ma J, Tan H, Turner-Wood K, Rahman MN, Chen G, Jia Z. Function Coupling Mechanism of PhuS and HemO in Heme Degradation. Scientific Reports. 7: 11273. PMID 28900278 DOI: 10.1038/S41598-017-11907-5 |
0.312 |
|
2016 |
Vukomanovic D, Rahman MN, Maines MD, Ozolinš TR, Szarek WA, Jia Z, Nakatsu K. Cysteine-independent activation/inhibition of heme oxygenase-2. Medical Gas Research. 6: 10-13. PMID 27826418 DOI: 10.4103/2045-9912.179341 |
0.455 |
|
2014 |
Vukomanovic D, Rahman MN, Bilokin Y, Golub AG, Brien JF, Szarek WA, Jia Z, Nakatsu K. In vitro Activation of heme oxygenase-2 by menadione and its analogs. Medical Gas Research. 4: 4. PMID 24533775 DOI: 10.1186/2045-9912-4-4 |
0.315 |
|
2014 |
Rahman M, Vukomanovic D, Vlahakis J, Szarek W, Nakatsu K, Jia Z. Structural insights into heme oxygenase-1 inhibition by azole-based compounds Acta Crystallographica Section a Foundations and Advances. 70: C831-C831. DOI: 10.1107/S2053273314091682 |
0.479 |
|
2013 |
Ye Q, Feng Y, Yin Y, Faucher F, Currie MA, Rahman MN, Jin J, Li S, Wei Q, Jia Z. Structural basis of calcineurin activation by calmodulin. Cellular Signalling. 25: 2661-7. PMID 24018048 DOI: 10.1016/J.Cellsig.2013.08.033 |
0.388 |
|
2013 |
Rahman MN, Vukomanovic D, Vlahakis JZ, Szarek WA, Nakatsu K, Jia Z. Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds. J R Soc Interface. 10: 20120697. PMID 23097500 DOI: 10.1098/Rsif.2012.0697 |
0.414 |
|
2012 |
Singh VK, Rahman MN, Munro K, Uversky VN, Smith SP, Jia Z. Free cysteine modulates the conformation of human C/EBP homologous protein. Plos One. 7: e34680. PMID 22496840 DOI: 10.1371/Journal.Pone.0034680 |
0.315 |
|
2012 |
Rahman MN, Vlahakis JZ, Vukomanovic D, Lee W, Szarek WA, Nakatsu K, Jia Z. A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition. Plos One. 7: e29514. PMID 22276118 DOI: 10.1371/Journal.Pone.0029514 |
0.446 |
|
2011 |
Vukomanovic D, McLaughlin BE, Rahman MN, Szarek WA, Brien JF, Jia Z, Nakatsu K. Selective activation of heme oxygenase-2 by menadione. Canadian Journal of Physiology and Pharmacology. PMID 22039914 DOI: 10.1139/Y11-091 |
0.325 |
|
2010 |
Roman G, Rahman MN, Vukomanovic D, Jia Z, Nakatsu K, Szarek WA. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone. Chemical Biology & Drug Design. 75: 68-90. PMID 19954435 DOI: 10.1111/J.1747-0285.2009.00909.X |
0.387 |
|
2010 |
Rahman MN, Vlahakis JZ, Roman G, Vukomanovic D, Szarek WA, Nakatsu K, Jia Z. Structural characterization of human heme oxygenase-1 in complex with azole-based inhibitors. Journal of Inorganic Biochemistry. 104: 324-30. PMID 19917515 DOI: 10.1016/J.Jinorgbio.2009.10.011 |
0.438 |
|
2009 |
Rahman MN, Vlahakis JZ, Vukomanovic D, Szarek WA, Nakatsu K, Jia Z. X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode. Journal of Medicinal Chemistry. 52: 4946-50. PMID 19601578 DOI: 10.1021/Jm900434F |
0.413 |
|
2009 |
Vlahakis JZ, Hum M, Rahman MN, Jia Z, Nakatsu K, Szarek WA. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring. Bioorganic & Medicinal Chemistry. 17: 2461-75. PMID 19268600 DOI: 10.1016/J.Bmc.2009.01.078 |
0.304 |
|
2008 |
Rahman MN, Vlahakis JZ, Szarek WA, Nakatsu K, Jia Z. X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors. Journal of Medicinal Chemistry. 51: 5943-52. PMID 18798608 DOI: 10.1021/Jm800505M |
0.505 |
|
2003 |
Hill BC, Becker L, Anand V, Kusmierczyk A, Marcovina SM, Rahman MN, Gabel BR, Jia Z, Boffa MB, Koschinsky ML. A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation. Archives of Biochemistry and Biophysics. 412: 186-95. PMID 12667482 DOI: 10.1016/S0003-9861(03)00032-8 |
0.637 |
|
2002 |
Rahman MN, Becker L, Petrounevitch V, Hill BC, Jia Z, Koschinsky ML. Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10. Biochemistry. 41: 1149-55. PMID 11802713 DOI: 10.1021/Bi010964I |
0.665 |
|
2002 |
Schneider M, Boffa M, Stewart R, Rahman M, Koschinsky M, Nesheim M. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. The Journal of Biological Chemistry. 277: 1021-30. PMID 11684677 DOI: 10.1074/Jbc.M104444200 |
0.507 |
|
2001 |
Rahman MN, Petrounevitch V, Jia Z, Koschinsky ML. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding. Protein Engineering. 14: 427-38. PMID 11477223 DOI: 10.1093/Protein/14.6.427 |
0.655 |
|
2001 |
Ye Q, Rahman MN, Koschinsky ML, Jia Z. High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand binding. Protein Science : a Publication of the Protein Society. 10: 1124-9. PMID 11369850 DOI: 10.1110/Ps.01701 |
0.65 |
|
1998 |
Rahman M, Jia Z, Gabel BR, Marcovina SM, Koschinsky ML. Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100. Protein Engineering. 11: 1249-56. PMID 9930675 DOI: 10.1093/Protein/11.12.1249 |
0.644 |
|
Show low-probability matches. |